$0.1441
-0.0159-9.94%
At close: Nov 13, 4:00 PM EST
$0.1475
0.00342.36%
After Hours: 7:58 PM EST
Theriva Biologics Inc (TOVX) Stock Price, Quote, News & History
TOVXAMEX
Theriva Biologics Inc. shares are trading higher Monday after announcing upcoming poster on VIRAGE phase 2b VCN-01 pancreatic cancer trial.
You can purchase shares of Theriva Biologics (AMEX:TOVX) through any online brokerage.
Other companies in Theriva Biologics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Theriva Biologics has a consensus price target of $1.00.
The stock price for Theriva Biologics (AMEX: TOVX) is $0.1475 last updated November 13, 2026 at 7:58 PM EST.
There are no upcoming dividends for Theriva Biologics.
Theriva Biologics does not have any upcoming earnings scheduled.
There is no upcoming split for Theriva Biologics.
Theriva Biologics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor...
